{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:47:34Z","timestamp":1790765254004,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2499-1","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T08:44:28Z","timestamp":1497257068000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-9585","authenticated-orcid":false,"given":"Aravind","family":"Swaminathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"du Cros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamsiya","family":"Mirgayosieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajabov","family":"Asladdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulfiya","family":"Dusmatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,12]]},"reference":[{"key":"2499_CR1","unstructured":"WHO treatment guidelines for drug-resistant tuberculosis 2016 update. \u00a9 World Health Organization 2016. Online http:\/\/who.int\/tb\/MDRTBguidelines2016.pdf?ua=1"},{"issue":"9","key":"2499_CR2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S2213-8587(14)70110-X","volume":"2","author":"AL Riza","year":"2014","unstructured":"Riza AL, Pearson F, et al. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinology. 2014 Sep;2(9):740\u201353.","journal-title":"Lancet Diabetes Endocrinology"},{"key":"2499_CR3","doi-asserted-by":"publisher","unstructured":"Jeon CY, Murray MB: Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008, 5: e152\u2013 10.1371\/journal.pmed.0050152","DOI":"10.1371\/journal.pmed.0050152"},{"key":"2499_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2013.12.005","volume":"80","author":"R Singh","year":"2014","unstructured":"Singh R, Kishore L, Kaur N. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol res. 2014;80:21\u201335.","journal-title":"Pharmacol res"},{"key":"2499_CR5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000354444","volume":"32","author":"Y-B Wu","year":"2013","unstructured":"Wu Y-B, Li H-Q, et al. CHOP\/ORP150 ratio in endoplasmic reticulum stress: a new mechanism for diabetic peripheral neuropathy. Cell Physiol Biochem. 2013;32:367\u201379.","journal-title":"Cell Physiol Biochem"},{"key":"2499_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12941-016-0156-y","volume":"15","author":"AA Agyeman","year":"2016","unstructured":"Agyeman AA, Ofori-Asenso R. Efficacy and safety profile of linezolid in multi drug-resistant and extensively drug-resistant tuberculosis: a systematic review and meta analysis. Ann Clin Micobiol Antimicrob. 2016;15:41.","journal-title":"Ann Clin Micobiol Antimicrob"},{"key":"2499_CR7","unstructured":"Anger HA, Dworkin F et al. Linezolid use for treatment of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis, NewYork City, 2000\u201306."},{"issue":"12","key":"2499_CR8","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.5588\/ijtld.12.0322","volume":"16","author":"PC Rose","year":"2012","unstructured":"Rose PC, Hallbauer UM, et al. Linezolid containing regimens for the treatment of drug resistant tuberculosis in south African children. Int J Tuberc Lung dis. 2012 Dec;16(12):1588\u201393.","journal-title":"Int J Tuberc Lung dis"},{"issue":"7","key":"2499_CR9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4065\/79.7.927","volume":"79","author":"JP Rho","year":"2004","unstructured":"Rho JP, Sia IG, et al. Linezolid associated peripheral neuropathy. Mayo Clin Proc. 2004;79(7):927\u201330.","journal-title":"Mayo Clin Proc"},{"key":"2499_CR10","doi-asserted-by":"crossref","first-page":"e1839","DOI":"10.1097\/MJT.0000000000000359","volume":"23","author":"VY Vishnu","year":"2016","unstructured":"Vishnu VY, Modi M, Goyal M, Lal V. Linezolid induced peripheral neuropathy. American J of Ther. 2016;23:e1839\u201341.","journal-title":"American J of Ther"},{"key":"2499_CR11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","volume":"42","author":"AS Vriese De","year":"2006","unstructured":"De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect dis. 2006;42:1111\u20137.","journal-title":"Clin Infect dis"},{"key":"2499_CR12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(04)01109-0","volume":"4","author":"AM Bressler","year":"2004","unstructured":"Bressler AM, Zimmer SM, et al. Peripheral neuropathy associated with prolonged use of linezolid. Lancet Infect dis. 2004;4:528\u201331.","journal-title":"Lancet Infect dis"},{"key":"2499_CR13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/dkl298","volume":"58","author":"IN Park","year":"2006","unstructured":"Park IN, Hong SB, et al. Efficacy and tolerability of daily half dose linezolid in patients with intractable multidrug-resistant tuberculosis. J Antimicrob Chemother. 2006;58:701\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"2499_CR14","doi-asserted-by":"crossref","unstructured":"Nambiar S, Rellosa N et al. Linezolid induced peripheral and optic neuropathy in children. Pediatrics. 2011 Jun; 127 (6): e: 1528\u201332.","DOI":"10.1542\/peds.2010-2125"},{"key":"2499_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinthera.2010.01.019","volume":"32","author":"E Chiappini","year":"2010","unstructured":"Chiappini E, Conti C, Galli L, et al. Clinical efficacy and tolerability of linezolid in pediatric patients: a systematic review. Clin Ther. 2010;32:66\u201388.","journal-title":"Clin Ther"},{"issue":"1","key":"2499_CR16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1378\/chest.77.1.98","volume":"77","author":"VS Nair","year":"1980","unstructured":"Nair VS, Lebrun M, Kass I. Peripheral neuropathy associated with ethambutol. Chest. 1980;77(1):98\u2013100.","journal-title":"Chest"},{"key":"2499_CR17","unstructured":"Varaine F, Rich ML. Tuberculosis: Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries. Medecins Sans Frontieres and Partners in Health; 2014 edition."},{"issue":"1\u20132","key":"2499_CR18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2165\/00003495-198223010-00003","volume":"23","author":"DJ Girling","year":"1982","unstructured":"Girling DJ. Adverse effects of antituberculosis drugs. Drugs. 1982;23(1\u20132):56\u201374.","journal-title":"Drugs"},{"key":"2499_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2251-6581-11-28","volume":"11","author":"AK Niazi","year":"2012","unstructured":"Niazi AK, Kalra S. Diabetes and tuberculosis: a review of the role of optimal glycemic control. Journal of Diabetes & Metabolic Disorders. 2012;11:28.","journal-title":"Journal of Diabetes & Metabolic Disorders"},{"key":"2499_CR20","doi-asserted-by":"crossref","unstructured":"Bodnar T, Starr K, Halter JB. Linezolid associated hypoglycemia in a 64 year old man with type 2 diabetes. Am J Geriatr Pharmacother 2011; Feb:9(1):88\u201392.","DOI":"10.1016\/j.amjopharm.2011.02.002"},{"key":"2499_CR21","doi-asserted-by":"crossref","first-page":"g1799","DOI":"10.1136\/bmj.g1799","volume":"348","author":"A Peltier","year":"2014","unstructured":"Peltier A, Goutman SA, Callaghan BC. Painful diabetic neuropathy. BMJ. 2014;348:g1799.","journal-title":"BMJ"},{"key":"2499_CR22","doi-asserted-by":"crossref","unstructured":"Harries AD, Kumar AMV, Satyanarayana S, Lin Y, Zachariah R, Lonnroth K, Kapur A. Diabetes mellitus and tuberculosis: programmatic management issues. Int J Tuberc Lung Dis 19(8): 879\u2013886.","DOI":"10.5588\/ijtld.15.0069"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2499-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T19:04:23Z","timestamp":1569438263000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2499-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2499"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2499-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,12]]},"article-number":"417"}}